World's Best Scientists 2026 revealed!
Familial Cancer
H-index 25

Familial Cancer

1389-9600

Published by: Springer

https://www.springer.com/journal/10689

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Medicine 1236 185 166 19

Additional Metrics

Number of Best Scientists*: 394
Documents by Best Scientists*: 298
Top 100 Ranked Scientists*: 11
SCIMAGO H-index: 70
SCIMAGO SJR: 1.018
Impact Factor: 2

Overview

Top Research Topics at Familial Cancer?

Familial Cancer tackles a plethora of topics, such as Internal medicine, Epidemiology, Cancer, Oncology and Human genetics. In Familial Cancer, Gastroenterology, Germline mutation and Pathology are investigated in conjunction with one another to address concerns in Internal medicine research. The journal explores topics in Germline mutation which can be helpful for research in disciplines like Cancer research, Gene mutation and Germline.

The journal focuses on Epidemiology but the discussions also offer insight into other areas such as Cohort, Family medicine, Gynecology, Family history and Genetic testing. The tackled Genetic testing research is interrelated with Genetic counseling which concerns subjects like Psychiatry. While work presented in Familial Cancer provided substantial information on Cancer, it also covered topics in Pediatrics and Age of onset.

Some problems in Oncology that were presented in the journal overlapped with concepts under Penetrance, Disease and Genotype. It focuses on Human genetics research as part of the broader topic of Genetics. The featured Lynch syndrome studies mainly concentrate on MSH2 but also cover areas of interest in MLH1 and MSH6.

  • Internal medicine (34.32%)
  • Epidemiology (32.69%)
  • Cancer (29.36%)

What are the most cited papers published in the journal?

  • Attenuated familial adenomatous polyposis (AFAP). A review of the literature (246 citations)
  • Lynch Syndrome Genes (216 citations)
  • Risk of cancer other than breast or ovarian in individuals with BRCA1 and BRCA2 mutations. (183 citations)

Research areas of the most cited articles at Familial Cancer:

The published articles tackle a plethora of topics, such as Internal medicine, Cancer, Epidemiology, Oncology and Lynch syndrome. In addition to Internal medicine research, the most cited articles aim to explore topics under Gastroenterology, Gene mutation and Pathology. The most cited papers explore issues in Lynch syndrome which can be linked to other research areas like Germline mutation, MSH2, Microsatellite instability and Human genetics.

What topics the last edition of the journal is best known for?

  • Cancer
  • Gene
  • Internal medicine

The previous edition focused in particular on these issues:

The topics of Internal medicine, Epidemiology, Human genetics, Cancer and Oncology are the focal point of discussions in the journal. Colorectal cancer, Breast cancer, Family history and Disease are among the concentrations of Internal medicine that garnered much attention in it. While Familial Cancer focused on Epidemiology, it was also able to explore topics like Family medicine, Lynch syndrome, Genetic testing and Cohort.

It explores issues in Human genetics which can be linked to other research areas like Bioinformatics, MEDLINE, Germline and Library science. Topics in Cancer were tackled in line with various other fields like Observational study, Medical diagnosis and Hereditary diffuse gastric cancer. The presented Oncology research focuses mostly on Germline mutation and, on occasion, topics in Gene mutation.

The most cited articles from the last journal are:

  • Report of the fifth meeting of the European Consortium 'Care for CMMRD' (C4CMMRD), Leiden, The Netherlands, July 6th 2019. (6 citations)
  • Chemoprevention in familial adenomatous polyposis: past, present and future. (6 citations)
  • Complete response of hereditary leiomyomatosis and renal cell cancer (HLRCC)-associated renal cell carcinoma to nivolumab and ipilimumab combination immunotherapy by: a case report. (5 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Familial Cancer (based on the number of publications) are:

  • Hans F. A. Vasen (35 papers) published 3 papers at the last edition, 1 more than at the previous edition,
  • Henry T. Lynch (33 papers) absent at the last edition,
  • John L. Hopper (22 papers) absent at the last edition,
  • Steven A. Narod (21 papers) published 1 paper at the last edition,
  • Margreet G. E. M. Ausems (19 papers) published 1 paper at the last edition, 3 less than at the previous edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Familial Cancer (based on the number of publications) are:

  • University of Melbourne (54 papers) absent at the last edition,
  • Leiden University Medical Center (42 papers) published 5 papers at the last edition, 1 more than at the previous edition,
  • Creighton University (36 papers) absent at the last edition,
  • Mayo Clinic (35 papers) published 2 papers at the last edition the same number as at the previous edition,
  • Leiden University (35 papers) published 1 paper at the last edition the same number as at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 4.49% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 20.00% were posted by at least one author from the top 10 institutions publishing in the journal. Another 24.71% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 22.35% of all publications and 32.94% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Institutional Collaboration in Familial Cancer Research

It would be beneficial to provide an understanding of the nature and extent of collaborations between different research institutions in the field of Familial Cancer research. This could shed light on the key players and the nature of their collaborations, fostering improved communication and synergy in future research endeavors. Several research collaborations exist amongst institutions in the field of Familial Cancer. To illustrate this, authors from diverse geographical and institutional backgrounds often co-author research papers. This cooperative effort epitomizes the integrated approach necessary for advancements in Familial Cancer research. For instance, in a recent publication, our Access to Genomic Information: Legal Implications, authors from the Institute of Human Genetics, Maastricht University, and Mayo Clinic worked together, showcasing a transatlantic collaborative effort. Collaborations like this are increasingly common within the research community, especially in areas like Familial Cancer that require a diverse range of expertise. Collaborations not only facilitate knowledge sharing but also provide opportunities for unique research perspectives that might not have been possible within one institution. For a deeper exploration of research collaborations and educational opportunities towards Familial Cancer, consider examining the lpn programs in wisconsin. These programs offer a wealth of information on Familial Cancer, as well as significant opportunities for partnerships and collaborations.

Top Publications

  • Ribosomal RNA 2'O-methylation as a novel layer of inter-tumour heterogeneity in breast cancer.

    Virginie Marcel;Janice Kielbassa;Virginie Marchand;Kundhavai S Natchiar

    (2020)
    65 Citations
  • Collaborative Group of the Americas on Inherited Gastrointestinal Cancer Position statement on multigene panel testing for patients with colorectal cancer and/or polyposis.

    Heald B;Hampel H;Church J;Dudley B

    (2020)
    45 Citations
  • The clinical features of polymerase proof-reading associated polyposis (PPAP) and recommendations for patient management.

    Claire Palles;Lynn Martin;Enric Domingo;Laura Chegwidden

    (2021)
    40 Citations
  • Renal cell carcinoma in young FH mutation carriers: case series and review of the literature

    J. A. Hol;M. C. J. Jongmans;A. S. Littooij;R. R. de Krijger

    (2020)
    37 Citations
  • Current recommendations for clinical surveillance and genetic testing in rhabdoid tumor predisposition: a report from the SIOPE Host Genome Working Group.

    M. C. Frühwald;K. Nemes;H. Boztug;M. C. A. Cornips

    (2021)
    34 Citations
  • Luminal androgen receptor breast cancer subtype and investigation of the microenvironment and neoadjuvant chemotherapy response

    (2022)
    33 Citations
  • Surveillance recommendations for DICER1 pathogenic variant carriers: a report from the SIOPE Host Genome Working Group and CanGene-CanVar Clinical Guideline Working Group.

    Jette J Bakhuizen;Helen Hanson;Karin van der Tuin;Fiona Lalloo

    (2021)
    32 Citations
  • Mainstreaming germline genetic testing for patients with pancreatic cancer increases uptake

    (2022)
    32 Citations
  • Current recommendations for cancer surveillance in Gorlin syndrome: a report from the SIOPE host genome working group (SIOPE HGWG).

    L Guerrini-Rousseau;M J Smith;C P Kratz;B Doergeloh

    (2021)
    32 Citations
  • Genetic predisposition to prostate cancer: an update

    Holly Ni Raghallaigh;Rosalind Eeles

    (2021)
    27 Citations

Related Online Degrees & Career Pathways

For those interested in healthcare but exploring alternatives to a traditional medical degree, several online pathways offer flexible, affordable options. One popular choice is medical coding, which plays a vital role in medical billing and insurance. Understanding how much does it cost to become a medical coder can help prospective students budget accordingly while pursuing this in-demand career.

Nursing is another accessible healthcare field with various entry points. Many students seek information on the easiest BSN program to get into to quickly start their journey toward becoming a registered nurse. These programs often balance comprehensive training with flexible admission criteria.

For those drawn to leadership roles within healthcare settings, pursuing a degree in health administration is an excellent option. Online health administration degree programs provide practical skills for managing healthcare facilities, improving patient care delivery, and navigating complex regulatory environments.

Considering costs is crucial when selecting a program. Exploring healthcare administration courses that offer affordability without sacrificing quality can make a significant difference for students balancing education with other commitments.

These related online degrees open doors to rewarding careers within the healthcare industry beyond traditional medicine, offering pathways tailored to different interests and goals.

Best Scientists Contributing to This Journal